Section 174 & 174A · Brief · Working level
Government contractors and Section 174: IR&D, direct-charge research, and the funded-research mirror
A contractor performing research under a cost-reimbursable or T&M government contract, with no financial risk and no retained rights, generally has no SRE expenditures — the costs are contract-performance costs. Fixed-price work, retained data rights, and independent R&D each change the answer, and the Section 41 funded-research rules run a parallel but not identical test.
For a government contractor, the Section 174 question is the reimbursed-research question wearing a FAR badge: research performed under contract generates SRE expenditures for the contractor only if the contractor bears financial risk of the research failing or retains rights to exploit the results. Under a cost-reimbursable or time-and-materials contract that assigns the government unlimited rights in the data, neither prong is met — the contractor's costs are ordinary performance costs, and the research economics belong to the customer. Under fixed-price development, the contractor eats overruns and generally holds the SRE cost. The framework carried from the capitalization-era guidance into the Section 174A expensing era intact.
IR&D versus direct-charge: the government-accounting map
Defense and aerospace contractors already sort research into two bins for cost-accounting purposes, and the tax analysis largely tracks the sort. Independent research and development (IR&D) under FAR 31.205-18 is self-initiated work — not required by any contract — recovered only indirectly, as overhead allocated across the contract base. The contractor chooses the projects, funds the work, and owns what results. That is the contractor's research in every sense: SRE expenditures under 174/174A, and generally the cleanest population for the research credit.
Direct-charge research is work a specific contract calls for, billed to that contract. Here contract type controls. Cost-plus and T&M terms pay the contractor win or lose — no financial risk. If the contract also gives the government unlimited rights and leaves the contractor nothing it can use commercially, the contractor has no SRE expenditures on that work. A firm-fixed-price development contract flips the risk prong: the price is set, the technical problems are the contractor's, and the SRE cost lands on the contractor even though the government ultimately pays the invoice.
Where the SRE cost typically lands, by arrangement:
| Arrangement | Financial risk on contractor? | Rights retained? | Contractor SRE cost? |
|---|---|---|---|
| IR&D (overhead-recovered) | Yes — self-funded projects | Yes | Yes |
| Cost-plus / T&M, unlimited government rights | No | No | Generally no |
| Cost-type with retained commercial/data rights | No | Yes | Yes — rights prong |
| Firm-fixed-price development | Yes | Varies | Generally yes |
The rights prong deserves respect. FAR data-rights clauses are graduated — unlimited rights, government purpose rights, limited rights — and many contracts leave the contractor free commercial use of technical data it developed. Under the 174 guidance's broad formulation, retaining any substantial right to use the results pulls the contractor's own performance costs into SRE treatment even on a riskless cost-type contract. That mattered acutely during 2022–2024 capitalization; today it mostly determines who holds any foreign-performed research on the 15-year schedule and who has domestic 174A deductions.
The Section 41 mirror — and where it cracks
Section 41(d)(4)(H) excludes "funded" research from the payer's credit, and Treas. Reg. §1.41-4A (eCFR Title 26) runs the same two dials: payment contingent on success, and substantial rights in the results. Fixed-price contractors have won this issue repeatedly — the Fairchild line holds that inspection-and-acceptance terms putting performance risk on the contractor defeat the funding exclusion — so fixed-price development commonly yields the contractor both the SRE cost and the credit, claimed on Form 6765. The doctrinal detail is in the funded-research exclusion.
But the tests are drafted separately and can diverge. The credit asks whether retained rights are substantial; the 174 guidance asks whether any exploitable right exists. A cost-type contractor with modest retained data rights can therefore hold 174 SRE expenditures while the same contract's payment terms render the research funded against it for credit purposes — deductions without a credit. The reverse mismatch is rarer but arguable. Run the two analyses independently, contract by contract, CLIN by CLIN where contract types mix.
Frequently asked questions
- Does a government contractor have Section 174 costs for research the government pays for?
- Usually not, if two things are true: the contract pays regardless of research outcome (cost-plus or time-and-materials terms) and the contractor retains no substantial rights to use the results in its own business. Then the costs are ordinary contract costs, deductible as incurred. Fixed-price development where the contractor eats overruns, or standard FAR data-rights clauses leaving the contractor commercial use rights, put SRE expenditures back on the contractor.
- How is IR&D treated differently from direct-charge contract research?
- Independent research and development is the contractor's own research — self-initiated, recovered only as an indirect overhead cost across contracts under FAR 31.205-18. Because the contractor bears the risk and owns the results, IR&D is squarely the contractor's Section 174/174A expenditure, and typically its strongest Section 41 credit population. Direct-charge research billed to a specific cost-type contract is generally the government's economics, not the contractor's SRE cost.
- Can research be excluded from a contractor's Section 41 credit but still be its Section 174 cost?
- Yes. The tests rhyme but differ. A fixed-price contract usually defeats the funded-research exclusion (contractor bears risk), giving the contractor both the 174 cost and potential credit. But a cost-type contract with retained rights can leave the contractor holding 174 SRE expenditures — the 'any right to use' formulation is broad — while payment-regardless-of-success terms still render the research funded against it for credit purposes.